Last $29.97 USD
Change Today -0.40 / -1.32%
Volume 122.2K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kyle W. Keese

Former Executive Vice President of Biosciences Division, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

52--

Background*

Mr. Kyle W. Keese served as Executive Vice President of BioSciences Division at Emergent BioSolutions Inc., from March 2011 to July 8, 2011. Mr. Keese served as Senior Vice President of Manufacturing Operations at Emergent BioSolutions Inc., from January 2008 to March 2011. Mr. Keese served as Senior Vice President of Corporate Affairs at Emergent BioSolutions from May 2007 to January 2008, Senior Vice President of Marketing and Communications since March 2006 to May ...

Read Full Background

Corporate Headquarters*

2273 Research Boulevard
Rockville, Maryland 20850

United States

Phone: 301-795-1800
Fax: 301-795-1899

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Tulane University
MBA
National University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $29.97 USD -0.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
--
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.